Terkko Navigator / Acta Oncologica

Can dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR patients.

Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study.

Identification of a novel resistance mechanism in venetoclax treatment and its prediction in chronic lymphocytic leukemia.

Self-reported questionnaires for lymphoedema: a systematic review of measurement properties using COSMIN framework.

Efficacy evaluation of anticancer agents in single-arm clinical trials: analysis of review reports from Pharmaceuticals and Medical Devices Agency.

Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc - effects and side effects.

Immune cell score, PD-L1 expression and prognosis in esophageal cancer.

Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.

Investigating the potential of deep learning for patient-specific quality assurance of salivary gland contours using EORTC-1219-DAHANCA-29 clinical trial data.

Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study.

Effects of football fitness training on lymphedema and upper-extremity function in women after treatment for breast cancer: a randomized trial.

Balance on slack line; diagnostic intensity and patient safety during the SARS-CoV-2 pandemic.

Monitoring expiratory carbon monoxide to study the effect of complete smoking cessation on definitive radiation therapy for early stage glottic carcinoma.

Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study.

Characteristics and outcomes of participants in colorectal cancer biomarker trials versus a real-world cohort.

Radiotherapy clinical trial enrollment during the COVID-19 pandemic.

Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy.

Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial).

Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study.

Covid-19 intensive care admissions and mortality among swedish patients with cancer.

Estimating the second primary cancer risk due to proton therapy compared to hybrid IMRT for left sided breast cancer.

The eHealth self-management application 'Oncokompas' that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?

Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016.

Incidence and malignant transformation of glottic precursor lesions in Denmark.

Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy.

Treatment outcomes of patients with salivary duct carcinoma undergoing surgery and postoperative radiotherapy.

Stereotactic ablative radiotherapy in patients with early-stage non-small cell lung cancer and co-existing interstitial lung disease.

IAEA support to radiotherapy dosimetry.

Re-irradiation for recurrent rectal cancer - a single-center experience.

Systematic use of patient reported outcome during radiotherapy for head and neck cancer: study protocol for the national DAHANCA 38 trial.

Incidence and time trends of childhood cancer in Denmark, 1943-2014.

50 Years of the IAEA/WHO postal dose audit programme for radiotherapy: what can we learn from 13756 results?

Smoking-adjusted risk of kidney cancer by occupation: a population-based cohort study of Nordic men.

An IAEA survey of radiotherapy practice including quality assurance extent and depth.

Radiation dose-painting with protons vs. photons for head-and-neck cancer.

Epidemiology of classic and nodular lymphocyte predominant hodgkin lymphoma in Finland in 1996-2015.

Isotoxic dose prescription level strategies for stereotactic liver radiotherapy: the price of dose uniformity.

Inguino-femoral radiotherapy in vulvar squamous cell carcinoma: clues to revised indications in patients with only one intracapsular lymph node metastasis.

The influence of errors in small field dosimetry on the dosimetric accuracy of treatment plans.

Is it safe to exercise during oncological treatment? A study of adverse events during endurance and resistance training - data from the Phys-Can study.

Elderly gynaecological cancer patients at risk for poor end of life care: a population-based study from the Swedish Register of Palliative Care.

Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer: feasibility of automatic data extraction for dose-response studies.

Frequency of discordance in programmed death-ligand 1 (PD-L1) expression between primary tumors and paired distant metastases in advanced cancers: a systematic review and meta-analysis.

Patient-reported outcomes 1 year after oesophageal cancer surgery.

Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?

Inequity in palliative care service full utilisation among patients with advanced cancer: a retrospective Cohort study.

Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer.

Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer.

CD30 expression and survival in posttransplant lymphoproliferative disorders.

Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking.